Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01480453 · ClinicalTrials.gov registry record
Outcomes Study of the TM Humeral Stem Used in Primary, Total or Hemi Shoulder Arthroplasty
A clinical trial, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- 67
- Enrollment target
NCT01480453: Clinical Trial study, sponsored by Zimmer Biomet.
NCT01480453 is a clinical trial that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 67 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01480453 was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- 67 participants
- Enrollment target
Study Summary
The objectives of this study are to obtain survival and outcome data on the Trabecular Metal Humeral Stem when used in primary, total or hemi shoulder arthroplasty.
Primary Outcome
Based on removal or intended removal of the device and determined using the Kaplan-Meier method.
Interventions
- DEVICE Trabecular Metal Humeral Stem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2011-01-02 |
| Est. Completion | 2018-12-31 |
Why NCT01480453 stopped before completion
NCT01480453 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 67 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Trabecular Metal Humeral Stem is the first listed.
NCT01480453 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01480453 about?
NCT01480453 is a clinical study titled "Outcomes Study of the TM Humeral Stem Used in Primary, Total or Hemi Shoulder Arthroplasty". The objectives of this study are to obtain survival and outcome data on the Trabecular Metal Humeral Stem when used in primary, total or hemi shoulder arthroplasty.
What is the current status of trial NCT01480453?
This trial is currently terminated. The enrollment target is 67 participants. The study started on 2011-01-02. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT01480453?
The interventions under investigation include: Trabecular Metal Humeral Stem (DEVICE).
Who is sponsoring clinical trial NCT01480453?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI